6515--Intent to sole source NEXTSEQ 2000 SEQUENCING SYSTEM
ID: 36C24223Q0975Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF242-NETWORK CONTRACT OFFICE 02 (36C242)ALBANY, NY, 12208, USA

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/cead1f63d7b74c5baa432c11754e2b1e/view
Timeline
  1. 1
    Posted Jul 18, 2023 1:25 PM
  2. 2
    Updated Oct 10, 2023 3:45 PM
  3. 3
    Due Jul 27, 2023 2:00 PM
Description

Title: Intent to Sole Source NextSeq 2000 Sequencing System

Department: Veterans Affairs, Department of

Procurement Target: NextSeq 2000 Sequencing System instrument

Summary: The Veterans Affairs, Department of intends to sole source a purchase order for the NextSeq 2000 Sequencing System instrument through Illumina Inc. This procurement is for the James J. Peters VAMC in Bronx, NY, specifically for COVID sequencing in the Research department. The NextSeq 2000 Sequencing System is an integrated system used for automated DNA clonal cluster generation, sequencing, and analysis. It is essential for the VAMC to sequence COVID and is believed to be the only suitable candidate. The system has the capability to run multiple samples at a great sequencing depth with a significantly lower cost. It is also compatible with FDA EUA approved COVIDseq test kit for detecting SARS-CoV-2. The system's high quality and accuracy in sequencing and analysis of variants make it especially useful in COVID research. The procurement includes the instrument, embedded touchscreen monitor, control software, DRAGEN Bio-IT secondary analysis pipelines, installation, training, and 12 months warranty. The NextSeq 2000 system is currently being used successfully at other VA sites. This notice of intent is not a request for competitive quotes, and no solicitation will be made available. Responses will be considered for future procurements.

Point(s) of Contact
Tina M CavalieriTina.Cavalieri@va.gov
(914) 737-4400 x2065
tina.cavalieri@va.gov
Files
Title
Posted
36C24223Q0975.docx
3/26/2024
Lifecycle
Title
Type
6515--Intent to sole source NEXTSEQ 2000 SEQUENCING SYSTEM
Currently viewing
Special Notice
Similar Opportunities
Illumina NextSeq 2000 System
Active
Health And Human Services, Department Of
Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF is planning to procure an Illumina NextSeq 2000 System. This system is typically used for analytical laboratory instrument manufacturing. The Department of Transfusion Medicine, Center for Cellular Engineering intends to upgrade from the existing Illumina NextSeq 550 to the Illumina NextSeq 2000 System. The system will be used for manufacturing cell and gene therapies for phase I and II clinical trials. The goal is to ensure potency assurance for cellular and gene therapy products. The Illumina NextSeq 2000 System is the only instrument compatible with the existing laboratory equipment and reagents. This acquisition will be conducted using simplified acquisition procedures and is exempt from competition requirements. Interested parties capable of providing similar products or services may submit a capability statement. Comments can be submitted electronically to the attention of Sheri Eiri, Contract Specialist, by August 1, 2024.
Intent to Sole Source - VISN2 North Cepheid Test Kits and Supplies
Active
Veterans Affairs, Department Of
The Department of Veterans Affairs intends to award a sole source contract to Cepheid, a California-based manufacturer, for the supply of specialized test kits and associated materials. The purpose is to meet the needs of multiple VA Medical Centers within VISN2, including Albany, Syracuse, Buffalo, and Bath/Canandaigua. The scope of work involves the supply of a comprehensive range of Genexpert test kits and related items. These are essential for detecting various medical conditions and pathogens, including Influenza A&B, SARS-CoV-2, C. difficile toxin, MRSA/SA, Chlamydia, and Neisseria gonorrhea. The items are to be supplied on a firm-fixed-price basis, with a planned period of performance spanning a base year and four additional option years. The eligibility criteria are focused on ensuring the applicant has the necessary capabilities and experience. As this is a sole source contract, specific qualifications or certifications are not outlined. However, the department emphasizes that Cepheid is the sole manufacturer that meets their specialized requirements. Funding for this contract is expected to come from the Veterans Health Administration. The contract value is estimated to range between $500,000 and $1 million. The contract will be awarded based on a Firm-Fixed-Price (FFP) arrangement. The submission process requires interested parties to submit a capability statement outlining their ability to meet the department's unique requirements. The deadline for submissions is 10:00 AM Eastern Standard Time on August 5, 2024, and all applications should be sent to the Contracting Officer, Morgan Weeks, via email. The evaluation criteria will primarily focus on the applicant's ability to meet the department's specialized needs and their compatibility with existing systems. The department seeks a manufacturer that can provide a comprehensive solution and has validated the use of their products within the VA Medical Centers. For any questions or clarifications, interested parties can contact Morgan Weeks by email at morgan.weeks1@va.gov or by phone at (607) 664-4708.
NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
Active
Health And Human Services, Department Of
NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS The Department of Health and Human Services, Department of Centers for Disease Control and Prevention, has issued a Special Notice for the procurement of Illumina reagents. These reagents are used for testing equipment, specifically the MiSeq, MiniSeq, and NextSeq instruments. Illumina, Inc. is the sole seller of the DNA prep library and sequencing kits for these instruments in the United States. No other products are compatible with these machines, making it necessary for the CDC to purchase the parts exclusively from Illumina, Inc. The continuity of sequencing influenza with these kits is critical for analyzing and comparing influenza data with public health laboratories and the World Health Organization. This procurement is being conducted as a sole source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested parties may submit proposals or express their interest and capability to respond to the requirement. The deadline for submission is 5:00 PM EDT on July 31, 2024.
NextSeq 2000 Bronze Service Agreement
Active
Health And Human Services, Department Of
NextSeq 2000 Bronze Service Agreement is being procured by the HEALTH AND HUMAN SERVICES, DEPARTMENT OF, specifically the NATIONAL INSTITUTES OF HEALTH, through the NIH National Institute of Environmental Health Sciences. The procurement notice type is Combined Synopsis/Solicitation. The service being procured falls under the industry category of Electronic and Precision Equipment Repair and Maintenance, with a NAICS code of 811210 and a PSC code of J066. The service being procured is a NextSeq 2000 Bronze Support Plan, with a quantity of 1. This service agreement is typically used for the maintenance and repair of NextSeq 2000 equipment, which is a high-throughput sequencing system used in genomics research. The place of performance for this procurement is in Durham, North Carolina, United States. The primary contact for this procurement is Brian Moyer, who can be reached via email at moyerbd@niehs.nih.gov or by phone at 9842873046. It is important to note that this is a notice of intent and not a request for quotations. The National Institute of Environmental Health Sciences intends to negotiate on a sole source basis with Illumina, Inc. for this service agreement. However, any responsible source that believes it is capable of meeting the NIEHS requirement may submit a capability statement. Responses to this posting must be submitted via email to moyerbr@niehs.nih.gov by August 8, 2023, 5:00 PM EST. The government will determine whether to compete this contract action based on the responses received. For any questions regarding this announcement, please contact Brian D. Moyer at the provided email address.
Notice of Intent (NOI) to Award Sole Source to Illumina, Inc. MiSeq Silver Support Maintenance Plan
Active
Commerce, Department Of
Notice of Intent (NOI) to Award Sole Source to Illumina, Inc. MiSeq Silver Support Maintenance Plan The U.S. Department of Commerce (DOC), National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service (NMFS), National Seafood Inspection Laboratory (NSIL) intends to award a sole source contract to Illumina Inc. for the MiSeq Silver Support Plan. This contract is for annual preventative maintenance and emergency repair service for the existing Illumina MiSeq gene sequencer. The MiSeq gene sequencer is highly specialized scientific equipment used for genetic sequencing. It is essential for the National Marine Fisheries Service's requirement for base year and four option years of preventative maintenance and emergency repair service. Illumina Inc. is uniquely qualified to meet this requirement as they are the only company that offers maintenance for the MiSeq platform. They possess proprietary technology and validated parts necessary for replacement or repair on the current machine, ensuring the MiSeq Whole Genome Sequencer maintains its instrument qualifications. The service to be provided by Illumina Inc. includes full coverage for parts, labor, and travel, reagent replacement upon hardware failure, remote technical support, two business day on-site response, control software and hardware updates, onsite applications support, and one preventative maintenance visit. The Government intends to negotiate a firm fixed-price contract with Illumina Inc. This notice of intent is not a request for competitive proposals, and no solicitation package is available. However, firms that believe they can fully meet the Government's requirements may submit substantiating documentation in writing within 15 days after publication of this synopsis. It is the Government's belief that only Illumina Inc. has the sole capability of providing the required services for the MiSeq gene sequencer.